Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
Episodes 226-240 of 272
Best Practices for Existing Epidermal Growth Factor Receptor (EGFR) Inhibitor Agents
Global Oncology AcademyBest Practices for Existing Epidermal Growth Factor Receptor (EGFR) Inhibitor Agents
Recent Breakthroughs in Head and Neck Cancer
Global Oncology AcademyRecent Breakthroughs in Head and Neck Cancer
Role of Immunotherapy in Head & Neck Cancer
Global Oncology AcademyRole of Immunotherapy in Head & Neck Cancer
Management of Recurrent Squamous Cell Carcinoma of the Head & Neck
Global Oncology AcademyManagement of Recurrent Squamous Cell Carcinoma of the Head & Neck
Key Developments within Head & Neck Cancer
Global Oncology AcademyKey Developments within Head & Neck Cancer
- advertisement
Current Recommendations: HPV Tumors in Head & Neck Cancers
Global Oncology AcademyCurrent Recommendations: HPV Tumors in Head & Neck Cancers
Targeted Therapy for Head & Neck Cancer
Global Oncology AcademyTargeted Therapy for Head & Neck Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Project Oncology®Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
- advertisement
Current Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
Global Oncology AcademyCurrent Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
The Importance of Colon Cancer Screening for Baby Boomers
Everyday Family MedicineThe Importance of Colon Cancer Screening for Baby Boomers
Patient Case Study: Role of Cetuximab in treatment of SCC Head and Neck Cancer Cancer
Global Oncology AcademyPatient Case Study: Role of Cetuximab in treatment of SCC Head and Neck Cancer Cancer





































